Liu Runyuan, Wu Saixuan, Liu Wanqing, Wang Lina, Dong Ming, Niu Weidong
School of Stomatology, Dalian Medical University, Dalian, China.
Front Bioeng Biotechnol. 2023 Aug 31;11:1249860. doi: 10.3389/fbioe.2023.1249860. eCollection 2023.
Bone regeneration is a dynamic process that involves angiogenesis and the balance of osteogenesis and osteoclastogenesis. In bone tissue engineering, the transplantation of mesenchymal stem cells (MSCs) is a promising approach to restore bone homeostasis. MSCs, particularly their small extracellular vesicles (sEVs), exert therapeutic effects due to their paracrine capability. Increasing evidence indicates that microRNAs (miRNAs) delivered by sEVs from MSCs (MSCs-sEVs) can alter gene expression in recipient cells and enhance bone regeneration. As an ideal delivery vehicle of miRNAs, MSCs-sEVs combine the high bioavailability and stability of sEVs with osteogenic ability of miRNAs, which can effectively overcome the challenge of low delivery efficiency in miRNA therapy. In this review, we focus on the recent advancements in the use of miRNAs delivered by MSCs-sEVs for bone regeneration and disorders. Additionally, we summarize the changes in miRNA expression in osteogenic-related MSCs-sEVs under different microenvironments.
骨再生是一个动态过程,涉及血管生成以及成骨与破骨细胞生成的平衡。在骨组织工程中,间充质干细胞(MSCs)的移植是恢复骨稳态的一种有前景的方法。MSCs,尤其是其小细胞外囊泡(sEVs),因其旁分泌能力而发挥治疗作用。越来越多的证据表明,来自MSCs的sEVs(MSCs-sEVs)所携带的微小RNA(miRNAs)可改变受体细胞中的基因表达并促进骨再生。作为miRNAs的理想递送载体,MSCs-sEVs将sEVs的高生物利用度和稳定性与miRNAs的成骨能力相结合,能够有效克服miRNA治疗中递送效率低的挑战。在本综述中,我们重点关注MSCs-sEVs所携带的miRNAs用于骨再生和疾病治疗的最新进展。此外,我们总结了在不同微环境下成骨相关MSCs-sEVs中miRNA表达的变化。